DATE: November 7, 2019
TIME: 9:00am PST, 12:00pm EST
In collaboration with Hematherix and Thermo Fisher, Dr. Laurent Mosnier is investigating a new treatment for acute traumatic bleeding using an engineered Factor V molecule. Acute traumatic bleeding is a major clinical issue without suitable prohemostatic treatment options. Most available prohemostatic drugs carry a high risk of thrombosis in acute traumatic bleeding. This webinar proposes a targeted therapy for acute traumatic bleeding using engineered Factor V molecules.
- Identify techniques to optimize expression levels of recombinant proteins
- Demonstrate how to improve yields of recombinant proteins using ExpiCHO
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.